Cambridge-based BiologIC, producer of the world’s first biocomputer, is marking a massive leap in its material understanding which will ultimately lead to faster time-to-market and cheaper drugs and vaccines – thanks to funding from Analysis for Innovators (A4I), a grant funding programme run by Innovate UK, the UK's innovation agency.
BiologIC’s pioneering 3D printed ‘lab-on-a-chip’ platforms are miniaturised devices that integrate multiple laboratory functions onto a single chip. These enable faster, more efficient, and cost-effective analysis of biological samples, with applications ranging from drug testing to point-of-care diagnostics. Dr Colin Barker, Chief Scientific Officer at BiologIC Technologies, said: “By the nature of them being 3D…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
